Shanghai Fosun Pharmaceutical Group Co Ltd (600196 SHG) stock market data APIs
¥28.5759
-0.04(-0.1%)
as of December 11, 2025
Try our APIs with
free plan!
Shanghai Fosun Pharmaceutical Group Co Ltd Financial Data Overview
Price chart is built with
Anychart
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. manufactures, distributes, and sells pharmaceutical products in Mainland China and internationally. The company offers pharmaceutical products for anti-tumor and immune modulation, metabolism and alimentary system, anti-infection, central nervous system, and cardiovascular system; and APIs and intermediates, including amino acid, tranexamic acid, levamisole hydrochloride, and clindamycin hydrochloride. It also provides mRNA vaccines for Covid-19; medical devices for medical cosmetology respiratory health and professional medical products; oncology, neuroscience and other specialty fields; and solutions for infections, tumors, the central nervous system, and chronic diseases. In addition, the company offers online and offline medical services, such as pharmaceuticals and medical devices, consumer healthcare and special commodities; specialized medical disciplines; and insurance services. Further, it is involved in the import and export of medical equipment and the provision of related and other consulting services and investment management. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Prev. Close
28.5759
Open
28.5359
High
29.3519
Low
28.4706
52 wk Range
22.75-33.1
Market Cap
75 627 M
P/E Ratio
22.8387
Shares Outstanding
2 118 M
Revenue
39 549 M
EPS
0.35
Dividends (Yield)
0.0113
Beta
0.73
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Shanghai Fosun Pharmaceutical Group Co Ltd (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Shanghai Fosun Pharmaceutical Group Co Ltd data using free add-ons & libraries
Get Shanghai Fosun Pharmaceutical Group Co Ltd Fundamental Data
Shanghai Fosun Pharmaceutical Group Co Ltd Fundamental data includes:
- Net Revenue: 39 549 M
- EBITDA: 4 878 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Shanghai Fosun Pharmaceutical Group Co Ltd Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: 2025-08-26
- EPS/Forecast: 0.28
Get Shanghai Fosun Pharmaceutical Group Co Ltd End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Shanghai Fosun Pharmaceutical Group Co Ltd News
New
Teva Partners with Fosun Pharma to Advance Novel Cancer Immunotherapy TEV-56278
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the most promising stocks according to Wall Street analysts. On June 16, Teva Pharmaceutical announced a collaboration agreement with China...
Fosun Pharma Announces 2024 Annual Results
Accelerates Globalization of Innovative Products with Operating Cash Flow Surging 31.13% YoY SHANGHAI, March 25, 2025 /PRNewswire/ -- On March 25, 2025, Shanghai Fosun Pharmaceutical (Group) Co., Lt...
Ardelyx Says China Approves New Drug Application for Hyperphosphatemia Treatment Tenapanor; Shares Up Pre-Bell
Ardelyx (ARDX) said Wednesday that a new drug application for tenapanor for the treatment of hyperph PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Fosun Pharma Received NMPA Approval for Wan Ti Le (Tenapanor Hydrochloride Tablets)
Bringing New Hope to Chinese Dialysis Patients with Hyperphosphatemia SHANGHAI, Feb. 26, 2025 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma; stock code: 600196.SH, 021...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
